UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________
FORM 8-K
_____________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): October 30, 2024
_____________________________
(Exact name of registrant as specified in its charter)
_____________________________
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
(Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, include area code) (212 ) 206-0763
N/A
(Former Name or Former Address, if Changed Since Last Report)
_____________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbols | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On October 30, 2024, The Vita Coco Company, Inc. (the “Company”) issued a press release announcing financial results for the three and nine months ended September 30, 2024 and other matters described in the press release. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
The information disclosed under this Item 2.02, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as expressly set forth in such filing.
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits.
Exhibit No. | Description | ||||
99.1 | |||||
104 | Cover Page Interactive Data File (embedded with Inline XBRL document) | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE VITA COCO COMPANY, INC. | ||||||||
Date: October 30, 2024 | By: | /s/ Corey Baker | ||||||
Name: Corey Baker | ||||||||
Title: Chief Financial Officer | ||||||||
Exhibit 99.1
The Vita Coco Company Reports Third Quarter 2024 Financial Results
Net Sales Decreased 4% to $133 million while Vita Coco Coconut Water Grew 8%
Net Income Increased $4 million to $19 million and Non-GAAP Adjusted EBITDA1 Decreased $4 million to $23 million
Company Raises Full Year Guidance for Net Sales and Adjusted EBITDA2
NEW YORK, NY – October 30, 2024 – The Vita Coco Company, Inc. (NASDAQ:COCO) (“Vita Coco” or “the Company”), a leading high-growth platform of better-for-you beverage brands, today announced financial results for the third quarter ended September 30, 2024.
Third Quarter and Year-To-Date 2024 Highlights Compared to Prior Year Period
•Net sales declined 4% in the third quarter to $133 million resulting in year-to-date being flat at $389 million.
•Vita Coco Coconut Water net sales growth of 8% in the third quarter and 5% year-to-date.
•Gross profit was $52 million in the third quarter, a decrease of $5 million and $157 million year-to-date, an increase of $17 million.
•Gross margin was 39% of net sales in the third quarter compared to 41% of net sales, and 41% of net sales year-to-date as compared to 36% of net sales.
•Net income was $19 million in the third quarter compared to net income of $15 million, and year-to-date was $53 million compared to $40 million.
•Net income per diluted share was $0.32 in the third quarter compared to $0.26, and was $0.89 per diluted share year-to-date compared to $0.68.
•Non-GAAP Adjusted EBITDA1 for the third quarter was $23 million compared to $27 million and year-to-date was $76 million, compared to $60 million.
Michael Kirban, the Company's Co-Founder and Executive Chairman, stated, "I am very proud of our team and our performance during the third quarter. The coconut water category remains one of the fastest growing categories in the beverage aisle, and we believe this growth is being fueled by our focus as the category leader in driving increased household adoption and new consumption occasions. Our reduced inventory availability during most of the quarter limited our ability to meet consumer demand. With an improving inventory situation, I expect accelerated growth for the balance of the year. Based on our expectation for continued strong category growth in 2025, I could not be more excited for what is to come."
Martin Roper, the Company’s Chief Executive Officer, said, “Our sales performance in the quarter was affected by our inventory flow, which was lower than we had planned due to the difficulty in obtaining ocean freight containers that started in the second quarter. We are pleased that we have weathered these shortages and, in late September, saw our product flow and availability in market improving. Based on continued strong category growth and improved inventory levels, we are raising our full year guidance for net sales and adjusted EBITDA."
Third Quarter 2024 Consolidated Results
Net sales decreased $5 million, or 4%, to $133 million for the third quarter ended September 30, 2024, compared to $138 million in the prior year period. The decrease in net sales was driven by declines in private label case equivalent ("CE") volume which more than offset the Vita Coco Coconut Water CE volume growth. The decline in private label was due to the reduction in private label oil sales, coupled with lower private label water volumes due primarily to supply constraints.
Gross profit was $52 million for the third quarter of 2024, compared to $56 million in the prior year period. Gross margin of 39% in the third quarter of 2024 decreased from 41% in the prior year period. Gross profit decrease was driven by lower overall volumes and increased transportation costs, which were partially offset by increased Vita Coco Coconut Water net pricing and price/mix effects in private label.
Selling, general and administrative ("SG&A") expenses in the third quarter of 2024 were $31 million, compared to $33 million in the prior year period. The decrease was largely due to the timing of marketing investments, which was partially offset by higher year on year personnel expenses.
Net income was $19 million, or $0.32 per diluted share, for the third quarter of 2024, compared to net income of $15 million, or $0.26 per diluted share, in the prior year period. Net income benefited from a gain on mark to market adjustment on derivative instruments, lower SG&A expenses and higher interest income driven by higher cash investments compared to the prior year period, partly offset by lower year-on-year gross profit.
Non-GAAP Adjusted EBITDA1 for the third quarter of 2024 was $23 million, compared to $27 million in the prior year period. The decrease in Adjusted EBITDA1 was primarily driven by lower gross profit resulting primarily from reduced volume and higher transportation costs, which were partially offset by higher Vita Coco Coconut Water net pricing, price/mix effects in private label, and lower SG&A.
Balance Sheet
As of September 30, 2024, the Company had cash and cash equivalents of $157 million, compared to $133 million as of December 31, 2023. There was no debt as of September 30, 2024 and December 31, 2023. Inventories as of September 30, 2024 totaled $65 million. On September 30, 2024, there were 56,731,839 shares of common stock outstanding.
On October 30, 2023, the Company's Board of Directors approved a share repurchase program authorizing the Company to repurchase up to $40 million of the Company's common stock. As of September 30, 2024, and to date, the Company has repurchased a total of 534,246 shares for an aggregate value of $12.8 million at an average share price of $23.97 with 112,702 shares repurchased during the most recent quarter.
Fiscal Year 2024 Full Year Outlook
The Company is raising its full year guidance for net sales and adjusted EBITDA:
•Expect 2024 net sales to be between $505 million and $515 million, with projected Vita Coco Coconut Water and private label coconut water volume growth, being offset by expected decreases in private label coconut oil business and price/mix effects.
•Full year gross margin expected to be between 37% and 39%, with recent increases on certain ocean freight routes expected to adversely affect gross margins in the fourth quarter.
•SG&A expenses expected to be flat to slightly down versus 2023.
•Forecasting adjusted EBITDA in the range of $80 million to $84 million.2
Uncertainty and instability of the current operating environment, global economies, and geopolitical landscape could affect this outlook and our future results.
Footnotes:
(1)Adjusted EBITDA represents earnings before interest, taxes, depreciation, and amortization as adjusted for certain items as set forth in the reconciliation table of U.S. GAAP to non-GAAP information and is a measure calculated and presented on the basis of methodologies other than in accordance with GAAP. Please refer to the Non-GAAP Financial Measures herein for further discussion and reconciliation of this measure to GAAP measures.
(2)GAAP Net Income 2024 outlook is not provided due to the inherent difficulty in quantifying certain amounts due to a variety of factors including the unpredictability in the movement in foreign currency rates, as well as future charges or reversals outside of the normal course of business.
Conference Call and Webcast Details
The Vita Coco Company will host a conference call and webcast at 8:30 a.m. ET today to discuss these results. To participate in the live earnings call and question and answer session, please register at https://register.vevent.com/register/BI8d315f452cbc496f9c6ab056102b481f and dial-in information will be provided directly to you. A slide presentation to support the webcast, and the live audio webcast will be accessible in the “Events” section of the Company’s Investor Relations website at https://investors.thevitacococompany.com. An archived replay of the webcast will be available shortly after the live event has concluded.
About The Vita Coco Company
The Vita Coco Company is a family of brands on a mission to reimagine what’s possible when brands deliver healthy, nutritious, and great tasting products that are better for consumers and better for the world. This includes its flagship coconut water brand Vita Coco, sustainably packaged water Ever & Ever, and protein-infused water PWR LIFT. The Company was co-founded in 2004 by Michael Kirban and Ira Liran and is a public benefit corporation and Certified B Corporation. Vita Coco, the principal brand within the Company’s portfolio, is the leading coconut water brand in the U.S. With electrolytes, nutrients, and vitamins, coconut water has become a top beverage choice among consumers after a workout, in smoothies, as a cocktail mixer, after a night out, and more.
Contacts
Investor Relations:
ICR, Inc.
investors@thevitacococompany.com
Non-GAAP Financial Measures
In addition to disclosing results determined in accordance with U.S. GAAP, the Company also discloses certain non-GAAP results of operations, including, but not limited to, Adjusted EBITDA, that include certain adjustments or exclude certain charges and gains that are described in the reconciliation table of U.S. GAAP to non-GAAP information provided at the end of this release. These non-GAAP measures are a key metric used by management and our board of directors to assess our financial performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance and because we believe it is useful for investors to see the measures that management uses to evaluate the Company. In addition, we believe the presentation of these measures is useful to investors for period-to-period comparisons of results as the items described below in the reconciliation tables do not reflect ongoing operating performance.
These measures are not in accordance with, or an alternative to, U.S. GAAP, and may be different from non-GAAP measures used by other companies. In addition, other companies, including companies in our industry, may calculate such measures differently, which reduces its usefulness as a comparative measure. Investors should not rely on any single financial measure when evaluating our business. This information should be considered as supplemental in nature and is not meant as a substitute for our operating results in accordance with U.S. GAAP. We recommend investors review the U.S. GAAP financial measures included in this earnings release. When viewed in conjunction with our U.S. GAAP results and the accompanying reconciliations, we believe these non-GAAP measures provide greater transparency and a more complete understanding of factors affecting our business than U.S. GAAP measures alone.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including but not limited to, statements regarding our future financial and operating performance, including our GAAP and non-GAAP guidance, our strategy, projected costs, prospects, expectations, plans, objectives of management, supply chain predictions, customer and supplier relationships, and expected net sales and category share growth.
The forward-looking statements in this release are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond the Company’s control. These factors include, but are not limited to, those discussed under the caption “Risk Factors” in our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and our other filings with the U.S. Securities and Exchange Commission ("SEC") as such factors may be updated from time to time and which are accessible on the SEC’s website at www.sec.gov and the Investor Relations page of our website at https://investors.thevitacococompany.com. Any forward-looking statements contained in this press release speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. We disclaim any obligation or undertaking to update or revise any forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.
Website Disclosure
We intend to use our websites, vitacoco.com and investors.thevitacococompany.com, as a means for disclosing material non-public information and for complying with the SEC's Regulation FD and other disclosure obligations.
THE VITA COCO COMPANY, INC.
CONSOLIDATED BALANCE SHEETS
(Amounts in thousands, except share data)
| September 30, 2024 | December 31, 2023 | ||||||||||
Assets | |||||||||||
Current assets: | |||||||||||
| Cash and cash equivalents | $ | 156,706 | $ | 132,537 | |||||||
| Accounts receivable, net of allowance of $2,257 at September 30, 2024, and $2,486 at December 31, 2023 | 78,600 | 50,086 | |||||||||
| Inventory | 64,905 | 50,757 | |||||||||
| Supplier advances, current | 1,265 | 1,521 | |||||||||
| Derivative assets | 1,299 | 3,876 | |||||||||
| Prepaid expenses and other current assets | 27,986 | 24,160 | |||||||||
| Total current assets | 330,761 | 262,937 | |||||||||
| Property and equipment, net | 2,440 | 2,136 | |||||||||
| Goodwill | 7,791 | 7,791 | |||||||||
| Supplier advances, long-term | 2,732 | 2,820 | |||||||||
| Deferred tax assets, net | 6,756 | 6,749 | |||||||||
| Right-of-use assets, net | 648 | 1,406 | |||||||||
| Other assets | 2,019 | 1,843 | |||||||||
| Total assets | $ | 353,147 | $ | 285,682 | |||||||
| Liabilities and Stockholders’ Equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 31,253 | $ | 21,826 | |||||||
| Accrued expenses and other current liabilities | 64,908 | 59,533 | |||||||||
| Notes payable, current | 10 | 13 | |||||||||
| Derivative liabilities | 4,533 | 1,213 | |||||||||
| Total current liabilities | 100,704 | 82,585 | |||||||||
| Notes payable, long-term | 5 | 13 | |||||||||
| Other long-term liabilities | 318 | 647 | |||||||||
| Total liabilities | $ | 101,027 | $ | 83,245 | |||||||
Stockholders’ equity: | |||||||||||
| Common stock, $0.01 par value; 500,000,000 shares authorized; 63,472,285 and 63,135,453 shares issued at September 30, 2024 and December 31, 2023, respectively 56,731,839 and 56,899,253 shares outstanding at September 30, 2024 and December 31, 2023, respectively | 635 | 631 | |||||||||
| Additional paid-in capital | 169,736 | 161,414 | |||||||||
| Retained earnings | 153,324 | 100,742 | |||||||||
| Accumulated other comprehensive loss | 156 | (649) | |||||||||
Treasury stock, 6,740,446 shares at cost as of September 30, 2024, and 6,236,200 shares at cost as of December 31, 2023. | (71,731) | (59,701) | |||||||||
| Total stockholders’ equity | 252,120 | 202,437 | |||||||||
| Total liabilities and stockholders’ equity | $ | 353,147 | $ | 285,682 | |||||||
THE VITA COCO COMPANY, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except for share and per share data)
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Net sales | $ | 132,906 | $ | 138,064 | $ | 388,720 | $ | 387,468 | |||||||||||||||
| Cost of goods sold | 81,344 | 81,893 | 231,244 | 246,542 | |||||||||||||||||||
| Gross profit | 51,562 | 56,171 | 157,476 | 140,926 | |||||||||||||||||||
| Operating expenses | |||||||||||||||||||||||
| Selling, general and administrative | 30,967 | 32,649 | 87,941 | 89,855 | |||||||||||||||||||
| Income (Loss) from operations | 20,595 | 23,522 | 69,535 | 51,071 | |||||||||||||||||||
| Other income (expense) | |||||||||||||||||||||||
| Unrealized gain/(loss) on derivative instruments | 2,592 | (3,959) | (5,896) | (1,758) | |||||||||||||||||||
| Foreign currency gain/(loss) | 550 | (1,211) | 472 | (430) | |||||||||||||||||||
| Interest income | 1,876 | 824 | 5,026 | 1,105 | |||||||||||||||||||
| Interest expense | — | (1) | — | (31) | |||||||||||||||||||
| Total other income (expense) | 5,018 | (4,347) | (398) | (1,114) | |||||||||||||||||||
| Income before income taxes | 25,613 | 19,175 | 69,137 | 49,957 | |||||||||||||||||||
| Income tax expense | (6,362) | (4,011) | (16,555) | (10,101) | |||||||||||||||||||
| Net income | $ | 19,251 | $ | 15,164 | $ | 52,582 | $ | 39,856 | |||||||||||||||
| Net income per common share | |||||||||||||||||||||||
| Basic | $ | 0.34 | $ | 0.27 | $ | 0.93 | $ | 0.71 | |||||||||||||||
| Diluted | $ | 0.32 | $ | 0.26 | $ | 0.89 | $ | 0.68 | |||||||||||||||
| Weighted-average number of common shares outstanding | |||||||||||||||||||||||
| Basic | 56,769,410 | 56,493,757 | 56,688,362 | 56,290,195 | |||||||||||||||||||
| Diluted | 59,314,805 | 59,271,757 | 59,099,179 | 58,494,045 | |||||||||||||||||||
THE VITA COCO COMPANY, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
| Nine Months Ended September 30, | |||||||||||
| 2024 | 2023 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income | $ | 52,582 | $ | 39,856 | |||||||
| Adjustments required to reconcile net income to cash flows from operating activities: | |||||||||||
| Depreciation and amortization | 540 | 503 | |||||||||
| (Gain)/loss on disposal of equipment | 13 | 19 | |||||||||
| Bad debt expense | (665) | 255 | |||||||||
| Unrealized (gain)/loss on derivative instruments | 5,896 | 1,758 | |||||||||
| Stock-based compensation | 6,649 | 7,126 | |||||||||
| Impairment loss on assets held for sale | — | 363 | |||||||||
| Noncash lease expense | 764 | 966 | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable | (26,910) | (37,234) | |||||||||
| Inventory | (13,974) | 33,815 | |||||||||
| Prepaid expenses, net supplier advances, and other assets | (2,585) | 5,215 | |||||||||
| Accounts payable, accrued expenses, and other liabilities | 13,667 | 17,361 | |||||||||
| Net cash provided by (used in) operating activities | 35,977 | 70,003 | |||||||||
| Cash flows from investing activities: | |||||||||||
| Cash paid for property and equipment | (849) | (533) | |||||||||
| Proceeds from sale of property and equipment | — | 5 | |||||||||
| Net cash used in investing activities | (849) | (528) | |||||||||
| Cash flows from financing activities: | |||||||||||
| Proceeds from exercise of stock awards | 1,676 | 5,915 | |||||||||
| Cash paid on notes payable | (10) | (18) | |||||||||
| Cash paid to acquire treasury stock | (12,030) | — | |||||||||
| Net cash provided by (used in) financing activities | (10,364) | 5,897 | |||||||||
| Effects of exchange rate changes on cash and cash equivalents | 333 | 212 | |||||||||
| Net increase/(decrease) in cash and cash equivalents | 25,097 | 75,584 | |||||||||
| Cash, cash equivalents and restricted cash at beginning of the period (1) | 132,867 | 19,629 | |||||||||
| Cash, cash equivalents and restricted cash at end of the period (1) | 157,964 | 95,213 | |||||||||
1 Includes $1,258 and $328 of restricted cash as of September 30, 2024 and 2023, respectively, that were included in other current assets.
RECONCILIATION FROM GAAP NET INCOME TO NON-GAAP ADJUSTED EBITDA
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
(in thousands) | (in thousands) | ||||||||||||||||||||||
| Net income | 19,251 | 15,164 | $ | 52,582 | $ | 39,856 | |||||||||||||||||
| Depreciation and amortization | 196 | 163 | 540 | 503 | |||||||||||||||||||
| Interest income | (1,876) | (824) | (5,026) | (1,105) | |||||||||||||||||||
| Interest expense | — | 1 | — | 31 | |||||||||||||||||||
| Income tax expense | 6,362 | 4,011 | 16,555 | 10,101 | |||||||||||||||||||
| EBITDA | 23,933 | 18,515 | 64,651 | 49,386 | |||||||||||||||||||
| Stock-based compensation (a) | 2,141 | 2,862 | 6,649 | 7,126 | |||||||||||||||||||
| Unrealized (gain)/loss on derivative instruments (b) | (2,592) | 3,959 | 5,896 | 1,758 | |||||||||||||||||||
| Foreign currency (gain)/loss (b) | (550) | 1,211 | (472) | 430 | |||||||||||||||||||
| Secondary Offering Costs (c) | — | — | (324) | 856 | |||||||||||||||||||
Other adjustments (d) | — | 329 | — | 329 | |||||||||||||||||||
| Adjusted EBITDA | $ | 22,932 | $ | 26,876 | $ | 76,400 | $ | 59,885 | |||||||||||||||
(a)Non-cash charges related to stock-based compensation, which vary from period to period depending on volume and vesting timing of awards and forfeitures. We adjusted for these charges to facilitate comparison from period to period.
(b)Unrealized gains or losses on derivative instruments and foreign currency gains or losses are not considered in our evaluation of our ongoing performance.
(c)Reflects other non-recurring expense/(income) related to costs associated with two secondary offerings in which Verlinvest Beverages SA sold shares of the Company in an underwritten public offering that closed on May 26, 2023 and a block trade that was executed on November 9, 2023. The amounts for the three and nine months ended September 30, 2023 relate to costs for the May 26, 2023 offering. The amounts for the three and nine months ended September 30, 2024 relate to an expense waiver of certain costs incurred during the November 9, 2023 block trade. The Company did not receive any proceeds from the sale of the shares.
(d)Reflects other charges primarily related to the impairment loss related to assets held for sale in 2023 and other non-recurring expenses.
SUPPLEMENTAL INFORMATION
NET SALES | |||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
(in thousands) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Americas segment | |||||||||||||||||||||||
Vita Coco Coconut Water | $ | 94,013 | $ | 89,683 | $ | 262,029 | $ | 253,825 | |||||||||||||||
Private Label | 16,489 | 28,257 | 63,897 | 77,366 | |||||||||||||||||||
Other | 1,744 | 2,706 | 6,913 | 7,490 | |||||||||||||||||||
Subtotal | $112,246 | $120,646 | $332,839 | $338,681 | |||||||||||||||||||
International segment | |||||||||||||||||||||||
Vita Coco Coconut Water | $ | 14,883 | $ | 11,350 | $ | 38,500 | $ | 33,628 | |||||||||||||||
Private Label | 4,800 | 5,421 | 14,768 | 13,140 | |||||||||||||||||||
Other | 977 | 647 | 2,613 | 2,019 | |||||||||||||||||||
Subtotal | $ | 20,660 | $ | 17,418 | $ | 55,881 | $ | 48,787 | |||||||||||||||
Total net sales | $ | 132,906 | $ | 138,064 | $ | 388,720 | $ | 387,468 | |||||||||||||||
COST OF GOODS SOLD & GROSS PROFIT | |||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
(in thousands) | 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||
Cost of goods sold | |||||||||||||||||||||||
Americas segment | $ | 68,681 | $ | 70,437 | $ | 196,195 | $ | 214,214 | |||||||||||||||
International segment | 12,663 | 11,456 | 35,049 | 32,328 | |||||||||||||||||||
Total cost of goods sold | $ | 81,344 | $ | 81,893 | $ | 231,244 | $ | 246,542 | |||||||||||||||
Gross profit | |||||||||||||||||||||||
Americas segment | $ | 43,563 | $ | 50,208 | $ | 136,643 | $ | 124,466 | |||||||||||||||
International segment | 7,999 | 5,963 | 20,833 | 16,460 | |||||||||||||||||||
Total gross profit | $ | 51,562 | $ | 56,171 | $ | 157,476 | $ | 140,926 | |||||||||||||||
Gross margin | |||||||||||||||||||||||
Americas segment | 38.8 | % | 41.6 | % | 41.1 | % | 36.8 | % | |||||||||||||||
International segment | 38.7 | % | 34.2 | % | 37.3 | % | 33.7 | % | |||||||||||||||
Consolidated | 38.8 | % | 40.7 | % | 40.5 | % | 36.4 | % | |||||||||||||||
| VOLUME (CE) | |||||||||||||||||
| Percentage Change - Three Months Ended September 30, 2024 vs. 2023 | |||||||||||||||||
Americas | International | Total | |||||||||||||||
| Vita Coco Coconut Water | 2.9 | % | 27.2 | % | 6.3 | % | |||||||||||
| Private Label | (32.1) | % | (4.7) | % | (27.0) | % | |||||||||||
| Other | (38.9) | % | 134.7 | % | (32.3) | % | |||||||||||
| Total volume (CE) | (6.8) | % | 17.4 | % | (3.1) | % | |||||||||||
| Percentage Change - Nine Months Ended September 30, 2024 vs. 2023 | |||||||||||||||||
Americas | International | Total | |||||||||||||||
| Vita Coco Coconut Water | 0.6 | % | 8.0 | % | 1.7 | % | |||||||||||
| Private Label | (7.6) | % | 18.5 | % | (3.1) | % | |||||||||||
| Other | (18.8) | % | 23.6 | % | (16.2) | % | |||||||||||
| Total volume (CE) | (1.7) | % | 10.9 | % | 0.2 | % | |||||||||||
Note: A CE is a standard volume measure used by management which is defined as a case of 12 bottles of 330ml liquid beverages or the same liter volume of oil.
*International Other excludes minor volume that is treated as zero CE